Big pharma is at a critical juncture, with J&J, Merck, and other companies set to experience substantial revenue losses from their blockbuster drugs
Johnson & Johnson (NYSE: JNJ) is being welcomed to the New York Stock Exchange. Analysts on Wall Street believe that certain pharmaceutical companies are well-prepared to counter the losses they will face
